1.
MMW Fortschr Med
; 166(9): 20, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38755361
2.
MMW Fortschr Med
; 166(8): 12-13, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38693360
3.
MMW Fortschr Med
; 166(8): 18, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38693367
4.
5.
MMW Fortschr Med
; 166(8): 18-19, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38693370
6.
MMW Fortschr Med
; 166(8): 18, 2024 05.
Article
in German
| MEDLINE
| ID: mdl-38693368
7.
MMW Fortschr Med
; 166(10): 10, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38806897
8.
MMW Fortschr Med
; 166(10): 5, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38806894
9.
MMW Fortschr Med
; 166(10): 18, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38806904
Subject(s)
COVID-19 Vaccines , COVID-19 , Pneumococcal Vaccines , Respiratory Syncytial Virus Infections , Humans , COVID-19/prevention & control , Pneumococcal Vaccines/administration & dosage , COVID-19 Vaccines/administration & dosage , Respiratory Syncytial Virus Infections/prevention & control , Respiratory Syncytial Virus Vaccines/immunology , SARS-CoV-2/immunology , Pneumococcal Infections/prevention & control
10.
MMW Fortschr Med
; 166(10): 68, 2024 06.
Article
in German
| MEDLINE
| ID: mdl-38806928
11.
12.
13.
MMW Fortschr Med
; 166(7): 21, 2024 04.
Article
in German
| MEDLINE
| ID: mdl-38637373
14.
15.
16.
17.
MMW Fortschr Med
; 166(4): 16-18, 2024 03.
Article
in German
| MEDLINE
| ID: mdl-38453839
18.
19.
20.
MMW Fortschr Med
; 166(2): 34, 2024 02.
Article
in German
| MEDLINE
| ID: mdl-38332279